Laboratory — Folate Testing
This Humana Medicare Advantage payment policy explains reimbursable and non-reimbursable laboratory folate tests and the circumstances in which serum folate testing is payable. It applies to providers submitting claims for Humana Medicare Advantage members.
No material clinical or coverage changes in this revision.
Folate Testing Coverage Criteria
Folate testing coverage rules
Covered when ALL of the following are met:
ALL of the following
Reimbursable test
- Measurement of serum folate (CPT 82746)
- Clinical indication: patient is diagnosed with megaloblastic or folate-deficiency anemia
- Jurisdiction: applies to all Medicare jurisdictions except states awarded to Novitas Solutions, Inc.
Not reimbursable tests
ANY of the following
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.